CareView Communications (CRVW) Depreciation & Amortization (CF) (2018 - 2023)
CareView Communications' (CRVW) quarterly Depreciation & Amortization (CF) came in at $61199.0 in Q4 2023, down 51.3% year-over-year from $125654.0 in Q4 2022, and down 22.39% quarter-over-quarter from $78859.0 in Q3 2023.
Analysis
CareView Communications (CRVW) Depreciation & Amortization (CF) (2018 - 2023) Analysis & Trends
CareView Communications has disclosed Depreciation & Amortization (CF) across 6 years of filings, most recently posting $61199.0 for Q4 2023.
- In Q4 2023, Depreciation & Amortization (CF) fell 51.3% year-over-year to $61199.0; the TTM figure through Sep 2024 stood at $61199.0 (down 84.67% YoY), while the FY2023 annual figure was $334676.0, down 33.27% from the prior year.
- Depreciation & Amortization (CF) came in at $61199.0 for Q4 2023 at CareView Communications, down from $78859.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $206239.0 in Q3 2020 to a low of $47642.0 in Q4 2020.
- Average Depreciation & Amortization (CF) over 5 years is $128767.6, with a median of $134941.0 recorded in 2022.
- Year-over-year, Depreciation & Amortization (CF) plunged 53.04% in 2019 and jumped 195.72% in 2021.
- Over 5 years, Depreciation & Amortization (CF) stood at $164882.0 in 2019, then plunged by 71.11% to $47642.0 in 2020, then soared by 195.72% to $140885.0 in 2021, then retreated by 10.81% to $125654.0 in 2022, then slumped by 51.3% to $61199.0 in 2023.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $61199.0 in Q4 2023, $78859.0 in Q3 2023, and $92109.0 in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 192.30 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 729.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 355.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 42.70 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 68.20 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 44.78 Mn |
| 10 | CareView Communications | 23.36 Mn | 21.44 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 61,199.00 |
| Sep 30, 2023 | 78,859.00 |
| Jun 30, 2023 | 92,109.00 |
| Mar 31, 2023 | 102,509.00 |
| Dec 31, 2022 | 125,654.00 |
| Sep 30, 2022 | 111,761.00 |
| Jun 30, 2022 | 129,165.00 |
| Mar 31, 2022 | 134,941.00 |
| Dec 31, 2021 | 140,885.00 |
| Sep 30, 2021 | 144,764.00 |
| Jun 30, 2021 | 143,192.00 |
| Mar 31, 2021 | 149,902.00 |
| Dec 31, 2020 | 47,642.00 |
| Sep 30, 2020 | 206,239.00 |
| Jun 30, 2020 | 114,631.00 |
| Mar 31, 2020 | 162,586.00 |
| Sep 30, 2019 | 164,882.00 |
| Jun 30, 2019 | 163,736.00 |
| Mar 31, 2019 | 171,928.00 |
| Sep 30, 2018 | 351,094.00 |